Completed PHASE4 INTERVENTIONAL 2-arm NCT00723307

Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study (CAMERA)

A Randomised Placebo-controlled Trial of Metformin on Progression of Carotid Atherosclerosis in Non-diabetic Patients With Cardiovascular Disease Treated With Conventional Risk Reducing Agents

Sponsor: Chief Scientist Office of the Scottish Government

Conditions Coronary Artery Disease

Interventions Metformin Placebo

Updated 5 times since 2017 Last updated: Dec 7, 2012 Started: Feb 28, 2009 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Chief Scientist Office of the Scottish Government and has accumulated 5 data snapshots since 2009. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chief Scientist Office of the Scottish Government
NHS Greater Glasgow and Clyde
Professor Naveed Sattar

Data source: University of Glasgow

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Glasgow, United Kingdom